
-
Exxon, Chevron turn page on legal fight as profits slip
-
Prosecutors call for PSG's Achraf Hakimi to face rape trial
-
Missing Kenya football tickets blamed on govt protest fears
-
India's Krishna and Siraj rock England in series finale
-
Norris completes 'double top' in Hungary practice
-
MLB names iconic Wrigley Field as host of 2027 All-Star Game
-
Squiban doubles up at women's Tour de France
-
International crew bound for space station
-
China's Qin takes 'miracle' second breaststroke gold at swim worlds
-
Siraj strikes as India fight back in England finale
-
Brewed awakening: German beer sales lowest on record
-
Indonesia volcano belches six-mile ash tower
-
US promises Gaza food plan after envoy visit
-
Musk's X accuses Britain of online safety 'overreach'
-
France says it cannot save contraceptives US plans to destroy
-
Russian drone attacks on Ukraine hit all-time record in July
-
Stocks sink on Trump tariffs, US jobs data
-
Newcastle reject Liverpool bid for Isak: reports
-
Cracks emerge in US jobs market as Fed officials sound warning
-
Douglass dedicates world gold to stricken US after 'rough' week
-
Senegal PM unveils economic recovery plan based on domestic resources
-
China's Qin milks 'miracle' second breaststroke gold at swim worlds
-
Swiss will try to negotiate way out of stiff US tariffs
-
US job growth weaker than expected in July as unemployment rises
-
Miracle man Qin wins second worlds gold ahead of blockbuster
-
Budapest mayor questioned as a suspect over Pride march
-
Thai-Cambodian cyberwarriors battle on despite truce
-
UK top court to rule on multi-billion pound car loan scandal
-
World economies reel from Trump's tariffs punch
-
French wine industry warns of 'brutal' impact from US tariffs
-
England openers run riot in India finale after Atkinson strikes
-
China's Qin wins 'miracle' second breaststroke gold at swim worlds
-
US envoy visits Gaza sites as UN says hundreds of aid-seekers killed
-
Steenbergen wins world 100m freestyle to deny O'Callaghan
-
Stocks slide as Trump's new tariff sweep offsets earnings
-
HIV-positive Turkmen man fears deportation, torture
-
India collapse in England decider as Atkinson strikes
-
Outrage grows in France over US plan to destroy contraceptives
-
Rees-Zammit to return to rugby after NFL dream ends
-
England say injured Woakes set to miss rest of India decider
-
Bayer sets aside more cash to deal with weedkiller woes
-
Pakistan inflict more T20 misery on West Indies
-
South Korea's Yoon resists questioning by lying in underwear
-
Stocks drop as Trump's new tariff sweep offsets earnings
-
El Salvador abolishes presidential term limits, allowing another Bukele run
-
Nintendo quarterly revenue surges thanks to Switch 2
-
Swiss to try to negotiate way out of stiff US tariffs
-
British Airways owner sees profit jump on 'strong' demand
-
Sand and dust storm sweeps across southern Peru
-
Battered Wallabies determined to deny Lions a whitewash
CMSC | -0.13% | 22.82 | $ | |
BCC | -1.17% | 82.84 | $ | |
SCS | -1.22% | 10.205 | $ | |
RBGPF | 0.69% | 74.94 | $ | |
GSK | 0.57% | 37.364 | $ | |
BTI | 1.33% | 54.405 | $ | |
CMSD | 0.17% | 23.31 | $ | |
NGG | 1.74% | 71.64 | $ | |
JRI | -0.44% | 13.073 | $ | |
SCU | 0% | 12.72 | $ | |
RYCEF | -2.75% | 13.8 | $ | |
BCE | 1.31% | 23.64 | $ | |
BP | -1.34% | 31.725 | $ | |
RELX | -0.87% | 51.44 | $ | |
RIO | -0.47% | 59.49 | $ | |
AZN | 0.73% | 73.63 | $ | |
VOD | 1.1% | 10.93 | $ |

Israeli desert town aims to be medical 'cannabis capital'
In Israel's Negev desert, far from the skyscrapers of Tel Aviv, the town of Yeruham hopes to cultivate an international reputation as the country's medical cannabis technology powerhouse.
Dozens of start-ups are already working on medical cannabis in Israel, where new legislation is expected to lead to further market growth in the fast-expanding sector.
Some believe that cannabis could help Yeruham tackle unemployment among its 12,000 residents, with initial efforts being led by a firm called CanNegev.
The company is known as an incubator, helping foster the growth of infant firms. CanNegev shelters four start-ups and is Israel's first medical cannabis technology incubator.
"We have decided to make medical cannabis the heart of our activity, here in Yeruham, one of the most peripheral towns in Israel -- a forgotten city," said CanNegev founder Zvi Bet Or.
He discovered a receptive audience in Tal Ohana, elected in 2018 to be Yeruham's first female mayor.
"My dream is to make Yeruham the capital of medical cannabis in Israel," Ohana told AFP.
"It's not every day that a new market is born" in the country, added Ohana, 37. "I told myself I have to do everything to be at the avant-garde of science and technology in this field."
CanNegev's modern building, facing the desert sands, stands out almost like a mirage, a symbol of the hoped-for future in the town whose stuccoed blocks of social housing were built in the 1950s for newly arrived immigrants.
But Yeruham is part of an economic priority zone that offers concessions to firms willing to set up there.
Ohana said the cannabis tech sector could transform the image of her town and help bring down its persistently higher-than-average unemployment, which is around eight percent.
"My goal is to create quality jobs" and to offer high incomes to attract a new population of workers, she said.
- World's leading importer -
Recreational use of cannabis is illegal though tolerated in Israel. However, authorities have encouraged its therapeutic use for the past decade to treat severe medical conditions and post-traumatic stress in former soldiers.
In October, Israel's parliament advanced a bill aimed at making medical cannabis more available.
It would expand a market that has already drawn scores of entrepreneurs including two former prime ministers: Ehud Olmert is business adviser to UNIVO Pharmaceuticals, and Ehud Barak chairs the board of InterCure.
About 100 start-ups are working on cannabis, said Dana Gourevich, Chief Technology Officer at the Israel Innovation Authority, adding that a quarter of those companies were founded in a single year, 2019.
"The medical cannabis ecosystem has received $60 million in investments in recent years," said Gourevich.
She said a key factor in developing Israel's homegrown cannabis industry was imports from overseas, especially Canada, where recreational use is legal.
According to health ministry data, Israel imported 22 tonnes of medical cannabis in 2021 compared to just over 14 tonnes a year before, making it the world's largest importer, the Israeli Cannabis Magazine noted.
By contrast, exporting cannabis is legal in theory but faces significant hurdles complying with international standards, Gourevich said.
- CBD for all -
The health ministry recently indicated it was examining the possibility of removing cannabidiol (CBD) from the list of dangerous drugs. The measure could open a new arena for companies to market CBD products at scale.
In southern Israel, near the city of Ashdod, BOL Pharma grows 400,000 cannabis plants annually on 3.5 hectares (8.6 acres), exclusively for therapeutic use.
"About 110,000 patients have (medical cannabis) licences today in Israel, but when CBD becomes available to everyone, millions of people, families, will be able to use it in cosmetics and everyday products," said Dvir Taler, 50, director of agriculture at BOL Pharma.
The company, currently the largest in the field of medical cannabis in Israel, partnered with the CanNegev incubator and supplies it with cannabis flowers for scientific experiments.
Taler said the incubator is developing a robot capable of autonomously harvesting flowers.
In its drive to become Israel's hub for green gold, the municipality of Yeruham has also allocated 50 hectares for the cultivation of medical cannabis, arguing that the desert climate is ideal for the crop's cultivation.
The user of that plot has not yet been determined.
Agreements have also been reached for two factories manufacturing non-medical cannabis products -- "self-care" goods such as oils used for cosmetics -- to be set up in Yeruham in the coming years, Ohana, the mayor said.
Resident Avraham Elbaz, 67, a retiree, said that "of course" he was in favour of these factories, which would help create jobs -- though he had not tried cannabis before.
"I have never smoked," he said.
M.A.Colin--AMWN